BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6874888)

  • 41. Distribution of glucagon-like peptide I in canine and feline pancreas and gastrointestinal tract.
    Vaillant CR; Lund PK
    J Histochem Cytochem; 1986 Sep; 34(9):1117-21. PubMed ID: 3755450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The peculiar processing of glucagon and glucagon-related peptides in patients after pancreatectomy.
    Tanjoh K; Tomita R; Hayashi N
    Hepatogastroenterology; 2002; 49(45):825-32. PubMed ID: 12064000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purification and sequence of rat oxyntomodulin.
    Collie NL; Walsh JH; Wong HC; Shively JE; Davis MT; Lee TD; Reeve JR
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9362-6. PubMed ID: 7937770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of acetylcholine on the secretion of gut glucagon immunoreactivity and gut glucagon-like immunoreactivity in pancreatectomized dogs.
    Yoshida T; Kondo M
    Endocrinol Jpn; 1980 Feb; 27(1):33-8. PubMed ID: 6993193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.
    Holst JJ; Schwartz TW; Lovgreen NA; Pedersen O; Beck-Nielsen H
    Int J Obes; 1983; 7(6):529-38. PubMed ID: 6360922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How concentrate feeding affects glucoregulatory hormones in ruminants: implications in bovine ketosis.
    Berzins R; Manns JG
    J Dairy Sci; 1979 Nov; 62(11):1739-45. PubMed ID: 575363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Half life of gastrointestinal glucagon-like immunoreactive materials.
    Tanaka R; Matsuyama T; Shima K; Sawazaki N; Tarui S; Kumahara Y
    Endocrinol Jpn; 1979 Feb; 26(1):59-63. PubMed ID: 436801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GIP, incretin and gastrointestinal disease.
    Lauritsen KB
    Dan Med Bull; 1983 Jun; 30(4):205-14. PubMed ID: 6347538
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
    Karmann H; Mialhe P
    Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Interaction between gastrointestinal hormones and endocrine regulation].
    Pfeiffer EF; Raptis S; Ziegler R
    Z Gastroenterol; 1976 Mar; 14 Suppl():70-94. PubMed ID: 8883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tissue distribution of glucagon, glucagonlike immunoreactivity, and insulin in the rat.
    Perez-Castillo A; Blázquez E
    Am J Physiol; 1980 Mar; 238(3):E258-66. PubMed ID: 6989265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A radioreceptor-assay for glucagon: binding of enteroglucagon to liver plasma membranes.
    Holst JJ
    Diabetologia; 1975 Jun; 11(3):211-9. PubMed ID: 168110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gel filtration pattern of immunoreactive glucagon secreted by the isolated, perfused, porcine pancreas.
    Holst JJ; Von Schenck H; Lindkaer S
    Scand J Clin Lab Invest; 1979 Feb; 39(1):47-52. PubMed ID: 523953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunocytochemical localization of glucagonlike and gastric inhibitory polypeptidelike peptides in the pancreatic islets and gastrointestinal tract.
    Smith PH
    Am J Anat; 1983 Sep; 168(1):109-18. PubMed ID: 6356867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut hormone release after intestinal resection.
    Besterman HS; Adrian TE; Mallinson CN; Christofides ND; Sarson DL; Pera A; Lombardo L; Modigliani R; Bloom SR
    Gut; 1982 Oct; 23(10):854-61. PubMed ID: 7117905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pancreatic glucagon (IRG), enteroglucagon (EG)].
    Kawabe K; Ito T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():493-5. PubMed ID: 16149559
    [No Abstract]   [Full Text] [Related]  

  • 58. Plasma enteroglucagon and plasma volume change after gastric surgery.
    Thomson JP; Bloom SR
    Clin Sci Mol Med; 1976 Aug; 51(2):177-83. PubMed ID: 954364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production and characterization of N-terminally and C-terminally directed monoclonal antibodies against pancreatic glucagon.
    Gregor M; Riecken EO
    Gastroenterology; 1985 Sep; 89(3):571-80. PubMed ID: 3839481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in glucagon processing occurring in the intestines of surgically stressed patients.
    Tanjoh K; Tomita R; Ishikawa Y; Izumi T; Utagawa S; Kinoshita K
    Hepatogastroenterology; 2007; 54(77):1462-6. PubMed ID: 17708277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.